Peripheral neuropathy decisions — 2025

The Board denied service connection for idiopathic peripheral neuropathy, right and left lower extremity, left foot infection, loss of toe, and right foot bone deterioration as the evidence did not support a finding that these conditions were caused by or related to military service.

The Board granted service connection for bilateral upper and lower extremity peripheral neuropathy, finding that the Veteran's current disability is proximately due to his service-connected prostate cancer and associated treatment.

The Board denied service connection for an anxiety disorder, right and left upper extremity peripheral neuropathy, and scar(s) of the neck. The rating in excess of 40 percent for lumbosacral strain was also denied.

The Board remands the claims for increased ratings for diabetes mellitus and bilateral lower extremity peripheral neuropathy to schedule VA examinations to determine the current severity of these disabilities.

The Board remands the claims for service connection for bilateral upper and lower extremity peripheral neuropathy to obtain additional evidence, including private medical records, and provide an adequate VA examination.

The Board denied the Veteran's claims for earlier effective dates for service connection for ulcerative colitis, neuropathy of both upper extremities, and a skin disability of the bilateral hands.

The appeal for service connection for bilateral upper extremity neuropathy and an increased rating for Diabetes Mellitus has been withdrawn and dismissed.

The Board granted service connection for hypertension prior to August 10, 2022, and the right upper extremity multifocal neuropathy, left upper extremity multifocal neuropathy, right lower extremity peripheral multifocal neuropathy, and left lower extremity peripheral multifocal neuropathy based on presumed herbicide exposure during service.

The Board denied service connection for peripheral neuropathy of the right lower extremity and remanded issues related to a rating increase for left knee replacement and service connection for right restless leg syndrome.

The Board remands the issues of entitlement to an increased initial rating for diabetic neuropathy of the left upper extremity and entitlement to a TDIU, to include consideration of entitlement to SMC under 38 U.S.C. § 1114(s), as further development is needed.

The Veteran is granted special monthly compensation based on the need for aid and attendance due to service-connected disabilities, other than bilateral lower extremity peripheral neuropathy, as well as based on loss of use of both legs due to service-connected bilateral lower extremity peripheral neuropathy.

The Board denied service connection for coronary artery disease, peripheral neuropathy of the left lower extremity, and diabetes mellitus, type II, as well as a total disability rating based on individual unemployability prior to March 14, 2017.

The Board granted a 20 percent disability rating for diabetic peripheral neuropathy, left lower extremity, effective August 28, 2015, and denied higher ratings for both the left and right lower extremities.

The Board denied service connection for sleep apnea, a skin disorder, bilateral hand neuropathy, glaucoma with severe visual impairment, hypertension, diabetes mellitus, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy.

The Board granted a 20 percent rating for right lower extremity diabetic peripheral neuropathy and denied an increased rating for left lower extremity diabetic peripheral neuropathy.

The Board granted service connection for an acquired psychiatric disorder and bilateral hearing loss, but denied service connection for traumatic brain injury (TBI), diabetes mellitus type II, lumbar condition, peripheral neuropathy of the right and left lower extremities.

The veteran withdrew his appeals for service connection for idiopathic peripheral neuropathy in all four extremities.

The Board remands the claim for service connection of Parkinson-like symptoms to obtain a medical opinion regarding the relationship between the Veteran's in-service Agent Orange exposure and his diagnosed conditions, including early demyelinating polyneuropathy.

The Board remands the claims for further development and to obtain additional evidence, including VA treatment records, Vet Center records, and a TERA examination under the PACT Act.

The Board granted earlier effective dates for the service connection of left and right lower extremity peripheral neuropathy but denied initial ratings in excess of 20 percent.